Astellas Pharma Europe B.V.
SpainAll drugs from this manufacturer
-
It is used in adults to control the immune system's response after an organ transplant (such as liver or kidney) and to prevent the body from rejecting the organ. It may also be used to treat an ongoing rejection of the transplanted organ.
Dosage form: capsules, hard, prolonged release
Active substance Dosage tacrolimus 0,5 mg -
It is used in adults to control the immune system response following an organ transplant (such as liver or kidney) and to prevent the body from rejecting it. It can also be used to treat rejection that is already occurring.
Dosage form: capsules, hard, prolonged release
Active substance Dosage tacrolimus 1 mg -
It is used in adults to control the immune system response following an organ transplant (such as liver or kidney) and to prevent the body from rejecting it. It may also be used to treat rejection that is already occurring if other treatments have not worked.
Dosage form: capsules, hard, prolonged release
Active substance Dosage tacrolimus 1 mg -
It is used in adults to control the immune system response following an organ transplant (such as liver or kidney) to prevent the body from rejecting it. It can also be used to treat rejection that is already occurring.
Dosage form: capsules, hard, prolonged release
Active substance Dosage tacrolimus 3 mg -
It is used to control the immune system response following an organ transplant (such as liver or kidney) to prevent the body from rejecting it. It can also be used to treat rejection that is already occurring in the liver, kidney, heart, or other organs.
Dosage form: capsules, hard, prolonged release
Active substance Dosage tacrolimus 5 mg -
It is used to treat the symptoms of an overactive bladder in adults (such as a sudden urge to urinate, going to the bathroom more often than normal, or being unable to control the release of urine) and to treat neurogenic detrusor overactivity in children between 3 and under 18 years of age.
Dosage form: tablets, prolonged-release
Active substance Dosage mirabegron 50 mg -
It is used to treat symptomatic anemia in adult patients with chronic kidney disease. It helps increase the red blood cell count and hemoglobin levels in the blood.
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 100 mg -
It is used to treat symptomatic anemia in adults with chronic kidney disease. It helps increase the number of red blood cells and hemoglobin levels in the blood.
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 150 mg -
It is used to treat symptomatic anemia in adults with chronic kidney disease. It helps to increase the red blood cell count and hemoglobin levels in the blood.
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 20 mg -
It is used to treat anemia with symptoms in adults with chronic kidney disease. It helps increase the number of red blood cells and hemoglobin levels in the blood.
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 50 mg -
It is used to treat anemia with symptoms in adults with chronic kidney disease. It helps increase the number of red blood cells and the hemoglobin level in the blood.
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 70 mg -
It is used to control the immune system response following an organ transplant (such as liver, kidney, or heart) to help the body accept the new organ. It can also be used to treat rejection of the transplanted organ.
Dosage form: suspension, oral for preparation from granules
Active substance Dosage tacrolimus monohydrate 0,2 mg -
It is used to control the immune system response following an organ transplant (such as liver, kidney, or heart) and to help the body accept the new organ. It can also be used to treat rejection of the transplanted organ.
Dosage form: suspension, oral for preparation from granules
Active substance Dosage tacrolimus monohydrate 1 mg -
It is used in adults to treat a type of bladder cancer (urothelial carcinoma) that has spread or cannot be removed by surgery. It can be administered alone or in combination with pembrolizumab.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 20 mg -
It is used in adults to treat a type of bladder cancer (urothelial carcinoma) that has spread or cannot be removed by surgery. It can be administered alone or together with another medication called pembrolizumab.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 30 mg -
It is used in menopausal women to reduce moderate to severe vasomotor symptoms, such as hot flashes or night sweats.
Dosage form: tablets, film-coated
Active substance Dosage fezolinetant 45 mg -
It is used to treat adults with acute myeloid leukemia (AML) related to an FLT3 gene alteration, specifically in cases where the disease has relapsed or has not improved with previous treatments.
Dosage form: tablets, film-coated
Active substance Dosage gilteritinib fumarate 44,2 mg -
It is used to treat adult men with prostate cancer that no longer responds to hormonal therapy or surgical treatment, that has metastasized and responds to hormonal therapy, or who have had prostate removal or radiation and show a rapid increase in PSA but without metastases.
Dosage form: tablets, film-coated
Active substance Dosage enzalutamide 40 mg